148 related articles for article (PubMed ID: 33301022)
1. Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.
MacInnis RJ; Knight JA; Chung WK; Milne RL; Whittemore AS; Buchsbaum R; Liao Y; Zeinomar N; Dite GS; Southey MC; Goldgar D; Giles GG; Kurian AW; ; Andrulis IL; John EM; Daly MB; Buys SS; Phillips KA; Hopper JL; Terry MB
J Natl Cancer Inst; 2021 Jun; 113(6):785-791. PubMed ID: 33301022
[TBL] [Abstract][Full Text] [Related]
2. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
Quante AS; Whittemore AS; Shriver T; Hopper JL; Strauch K; Terry MB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25956172
[TBL] [Abstract][Full Text] [Related]
3. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
4. Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.
Ghoncheh M; Ziaee F; Karami M; Poorolajal J
Clin Breast Cancer; 2017 Jun; 17(3):e113-e118. PubMed ID: 28216418
[TBL] [Abstract][Full Text] [Related]
5. Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk.
Allman R; Mu Y; Dite GS; Spaeth E; Hopper JL; Rosner BA
Breast Cancer Res Treat; 2023 Apr; 198(2):335-347. PubMed ID: 36749458
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
[TBL] [Abstract][Full Text] [Related]
7. Performance of risk prediction models in breast cancer screening among women in Cyprus.
Danladi C; Serakinci N
East Mediterr Health J; 2022 Dec; 28(12):888-895. PubMed ID: 36573569
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models.
Laitman Y; Simeonov M; Keinan-Boker L; Liphshitz I; Friedman E
Genet Res (Camb); 2013 Dec; 95(6):174-7. PubMed ID: 24506973
[TBL] [Abstract][Full Text] [Related]
9. Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study.
Brooks JD; Mah A; Christensen RAG; Arneja J; Eisen A; Chiarelli AM
Genet Med; 2023 Jun; 25(6):100820. PubMed ID: 36919844
[TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models.
Li SX; Milne RL; Nguyen-Dumont T; Wang X; English DR; Giles GG; Southey MC; Antoniou AC; Lee A; Li S; Winship I; Hopper JL; Terry MB; MacInnis RJ
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 33977228
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.
Ståhlbom AK; Johansson H; Liljegren A; von Wachenfeldt A; Arver B
Fam Cancer; 2012 Mar; 11(1):33-40. PubMed ID: 22124624
[TBL] [Abstract][Full Text] [Related]
12. Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC).
Zeinomar N; Knight JA; Genkinger JM; Phillips KA; Daly MB; Milne RL; Dite GS; Kehm RD; Liao Y; Southey MC; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; John EM; MacInnis RJ; Hopper JL; Terry MB
Breast Cancer Res; 2019 Nov; 21(1):128. PubMed ID: 31779655
[TBL] [Abstract][Full Text] [Related]
13. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
15. Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre.
MacInnis RJ; Bickerstaffe A; Apicella C; Dite GS; Dowty JG; Aujard K; Phillips KA; Weideman P; Lee A; Terry MB; Giles GG; Southey MC; Antoniou AC; Hopper JL
Br J Cancer; 2013 Sep; 109(5):1296-301. PubMed ID: 23942072
[TBL] [Abstract][Full Text] [Related]
16. Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
Powell M; Jamshidian F; Cheyne K; Nititham J; Prebil LA; Ereman R
Clin Breast Cancer; 2014 Jun; 14(3):212-220.e1. PubMed ID: 24461459
[TBL] [Abstract][Full Text] [Related]
17. Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations.
Ming C; Viassolo V; Probst-Hensch N; Dinov ID; Chappuis PO; Katapodi MC
Br J Cancer; 2020 Sep; 123(5):860-867. PubMed ID: 32565540
[TBL] [Abstract][Full Text] [Related]
18. iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management.
Collins IM; Bickerstaffe A; Ranaweera T; Maddumarachchi S; Keogh L; Emery J; Mann GB; Butow P; Weideman P; Steel E; Trainer A; Bressel M; Hopper JL; Cuzick J; Antoniou AC; Phillips KA
Breast Cancer Res Treat; 2016 Feb; 156(1):171-82. PubMed ID: 26909793
[TBL] [Abstract][Full Text] [Related]
19. Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort.
Zeinomar N; Phillips KA; Daly MB; Milne RL; Dite GS; MacInnis RJ; Liao Y; Kehm RD; Knight JA; Southey MC; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; John EM; Hopper JL; Terry MB
Int J Cancer; 2019 Jul; 145(2):370-379. PubMed ID: 30725480
[TBL] [Abstract][Full Text] [Related]
20. Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines - Pilot Study.
Krajc M; Gareth Evans D; Blatnik A; Lokar K; Žagar T; Tomšič S; Žgajnar J; Zadnik V
Zdr Varst; 2020 Dec; 59(4):211-218. PubMed ID: 33133277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
